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Controlling hunger between meals is a challenge for many individuals. This manuscript comprises 2
sequential clinical trials investigating the effects of psyllium (Metamucil) on satiety, both using a ran-
domized, double-blind, placebo-controlled cross-over design. The ﬁrst study determined the effects of
3.4 g, 6.8 g, and 10.2 g of psyllium taken before breakfast and lunch for 3 days. The second study
determined the effects of 6.8 g (taken before breakfast and lunch on Days 1 and 2 and before breakfast on
Day 3) on the satiety of participants receiving an energy restricted meal in the morning (breakfast) for 3
days. Efﬁcacy endpoints were mean inter-meal hunger, desire to eat, and Satiety Labeled Intensity
Magnitude Visual Analog Scale scores. In Study 1, all 3 psyllium doses resulted in directional or statis-
tically signiﬁcant mean reductions in hunger and desire to eat, and increased fullness between meals
compared to placebo, with both higher doses better than placebo or 3.4 g. The 6.8 g dose provided more
consistent (p  0.013) satiety beneﬁts versus placebo. In Study 2, satiety was assessed similarly to Study
1. A signiﬁcant (p  0.004) decrease in the 3-day mean hunger and desire to eat, as well as an increase in
fullness for psyllium relative to placebo was observed. Most adverse events were mild gastrointestinal
symptoms and were similar for psyllium compared to placebo. These results indicate that psyllium
supplementation contributes to greater fullness and less hunger between meals.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A common difﬁculty faced by those attempting to change their
habitual eating pattern to moderate energy intake or body weight
is to control appetite throughout the day (Rigaud, Paycha,
Meulemans, Merrouche, & Mignon, 1998). This is challenging,
because appetite is inﬂuenced by a multitude of biological,
behavioral, and environmental stimuli. (Bergmann, Chassany, Petit,
Triki, Caulin, & Segrestaa, 1992). It is well established that more
energy-dense foods (high energy/g) often have lower satiety index
scores and produce shorter inter-meal intervals than foods with
low energy density (Blundell, Green, & Burley, 1994; Hylander &
Rӧssner, 1983). Alternatively, bulky and well-hydrated foods that
are high in protein and ﬁber often have higher satiety index scores
and produce longer inter-meal intervals with low hunger.s index; REE, resting energy
de; VAS, visual analog scale.
ience, Purdue University, 212
907-2059, USA.
.
Ltd. This is an open access article uAlthough being satiated after a meal is no guarantee of lower
total daily energy intake, hunger plays an important role when
adhering to diets that aim to control energy intake (Burton, Smit, &
Lightowler, 2007; Das et al. 2009; Gilhooly et al. 2008; Martin,
O’Neil, & Pawlow, 2006; Wing et al. 2008). Furthermore, complex
dietary regimens are not likely to be well accepted by most people
trying to maintain a sense of satiety while reducing their energy
intake. Energy restriction programs could therefore be improved
through the use of familiar products that enhance satiety such as a
cereal enriched with ﬁber (Gilhooly et al. 2008).
Fibers often promote higher satiety when compared with
digestible complex carbohydrates and simple sugars. There are a
large number of dietary ﬁber technologies reported in the literature
and commercially available to replace energy-rich foods and for
management of energy intake. Others have calculated that an
additional 14 g/day of dietary ﬁber provided with meals for more
than 2 days could result in up to a 10% decrease in daily energy
intake (Howarth, Saltzman, & Roberts, 2001). Thus, it is reasonable
to hypothesize that the use of dietary soluble viscous ﬁber may be a
useful tool for long-term healthy weight management (De Graaf,
Blom, Smeets, & Staﬂeu, 2004; Hoad et al. 2004; Lyon & Kacinik,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Dietary soluble viscous ﬁber such as psyllium can slow gastric
emptying and decrease the speed of absorption of fat and glucose
exposing more distal parts of the small intestine to these energy-
yielding nutrients leading to a prolonged sense of fullness
(Bergmann et al. 1992; Delargy, O’Sullivan, Fletcher, & Blundell,
1997; Hylander & Rossner, 1983; Rigaud et al., 1998; Turnbull &
Thomas, 1995; Wanders et al. 2011).
The majority of the research to date has demonstrated that
consumption of psyllium, a gel forming non-fermentable viscous
soluble ﬁber can reduce the risks of metabolic conditions by
improving glucose levels and insulin response, as well as lipid
proﬁle in humans (McRorie, 2015). There are several randomized,
well-controlled clinical studies that assessed doses of 6e15 g/day
(most studies at 10 g/day) psyllium in cardiometabolic conditions
(McRorie, 2015). These studies show that the cholesterol lowering
effects of psyllium range from 2% to 20% for total cholesterol,
and 6% to 24% for LDL-cholesterol versus placebo (Anderson,
Floore, Geil, Spencer, & Balm, 1991; Cicero, Derosa, Bove, Imola, &
Borghi, Gaddi, 2010; McRorie, 2015). Psyllium supplementation
can indeed reduce the risks of metabolic conditions by improving
glucose levels and insulin response, as well as lipid proﬁle in
humans (McRorie, 2015).
A previous study using ultrasound with obese patients, docu-
mented that psyllium moderately but signiﬁcantly delays gastric
emptying when provided with a solid meal (Bergmann et al. 1992).
Furthermore, the changes in gastric emptying were associated with
a delayed appearance of hunger assessed by visual analog scale
(VAS). Although this was a single meal study the authors proposed
that dietary supplementation with psyllium ﬁber could be used to
control satiety following repeated meals. These results and further
clinical evidence of a post-meal satiety effect for psyllium
(Bergmann et al., 1992; Delargy et al., 1997; Hylander & Rossner,
1983; Rigaud et al., 1998; Salas-Salvado et al., 2008; Turnbull &
Thomas, 1995) suggest that psyllium may be a useful dietary sup-
plement to improve satiety and enhance adherence to energy-
restricted dietary regimens.
Since previous studies had not investigated the effects of
different doses of psyllium ﬁber and the reproducibility and
persistence of the satiety effect across multiple meals, we under-
took a systematic study plan to examine these variables. The
studies described here show the results of 2 randomized, double-
blind, placebo-controlled cross-over studies evaluating dose
response and multiple dosing effects of dietary psyllium ﬁber on
the inter-meal satiety of healthy volunteers. The studies were
designed to isolate as much as possible the effects of psyllium ﬁber
on subjective sensations of satiety by ﬁxing the intake of energy
and the composition of food.
2. Material and methods
This manuscript comprises 2 sequential clinical trials (Study 1
and Study 2) investigating the effects of psyllium on satiety indices.
These were randomized, double-blind, cross-over placebo-
controlled studies. All individual were exposed to all treatments
after 4e5 days of washout between periods.
The ﬁrst was a study to determine the effects of 3 different doses
of psyllium ﬁber (3.4 g, 6.8 g and 10.2 g) taken before a regular
breakfast and lunch for 3 consecutive days. The second study
determined the effects of 6.8 g of psyllium ﬁber given before meals
also for 3 days (before breakfast and lunch on Days 1 and 2 and
before breakfast on Day 3) on satiety of participants receiving en-
ergy restricted meals. The amount of food energy provided at the
morning breakfast was lower in the second study in order to see if
psyllium would increase satiety under a reduced energy condition.Both studies were conducted in accordance with the Interna-
tional Conference on Harmonization (ICH) Harmonized Tripartite
Guideline for Good Clinical Practice (GCP), 1997; the US Code of
Federal Regulations (CFR) Title 21 parts 50, 56 and 312 and the
guidelines stipulated in the Declaration of Helsinki. All procedures
involving human subjects were approved by the Western IRB
(Western Institutional Review Board, 3535 7th Avenue SW, Olym-
pia, WA 98502). Before any study procedures were performed, all
participants were informed in detail about the test products to be
administered and the nature of the clinical investigation, including
the risks and potential discomforts that could be expected. Written
informed consent was obtained from all participants following
basic elements as speciﬁed by the US CFR (Title 21, CFR 50.25 and
50.27).
The studies were performed in a Phase I pharmacology unit
(MedPace, Cincinnati, Ohio) and healthy participants were
recruited from the MedPace database or by advertisement in local
media. Participants were screened according to the inclusion/
exclusion criteria from 10 to 3 days (Screening Period, Visit 1)
and signed informed consent before randomization. The main in-
clusion criteria were: men and women between 18 and 55 years of
age that ate breakfast and lunch daily, had 1-2 bowel movements
per day that are typically rated as 3, 4, or 5 on the Bristol Stool Form
Scale (Lewis & Heaton, 1997), generally healthy (medical history),
body mass index (BMI)  18.5 but < 32 kg/m2, and willing to
maintain their current lifestyle habits for the duration of the study
(e.g., exercise and diet). Exclusion criteria included a history of
cardiovascular, hepatic, renal, neurologic, hematologic/oncologic
metabolic, endocrine, or gastrointestinal (GI) disease (e.g., peptic
ulcer disease, gastroesophageal reﬂux disease, malabsorptive dis-
ease, inﬂammatory bowel disease, acrodermatitis enteropathica).
Individuals with a history of an eating disorder; difﬁculty swal-
lowing or history of GI surgery (except appendectomy) or had a
signiﬁcant psychiatric disorder (e.g., major depression, psychoses)
or had a history of allergic reactions were excluded. Participants
with a score <30 on a 100 mm VAS for palatability of study meals
(Mattes, 2007), or a score > 20 on the Eating Attitudes Test (EAT-26)
(Garner, Olmsted, Bohr, & Garﬁnkel, 1982) were excluded.
Eligible participants were randomly assigned to test product
sequences on the ﬁrst day of Test Period 1. Treatment periods were
separated by a minimum 4-day washout during which no test
product was administered.
2.1. Energy intake and satiety assessment instruments and
procedures common to both studies
Satiety was assessed subjectively by the participants using 3
different rating scales designed to measure their degree of hunger,
desire to eat, and satiety. Participants were asked to complete these
scales on each treatment day immediately before drinking the
assigned test product prior to breakfast, immediately after break-
fast, at half-hour intervals after breakfast until lunch, immediately
after lunch, and at half-hour intervals after lunch until dinner.
Participants were seated separately at a distance discouraging be-
tween subject interaction during meal consumption to avoid bias
and interference with the assessment of satiety variables.
Participants had a single meal composition choice that varied by
amount, as determined by individual energy requirements. Indi-
vidual energy requirements in these studies were estimated with
the participant at rest and conﬁned to the study site facility prior to
the ﬁrst day of a Test Period and were based onweight, height, age,
and gender using predictive equations for resting energy expen-
diture (REE) described by Mifﬂin, St Jeor, Hill, Scott, Daugherty, and
Koh (1990). Using these equations, participants were assigned a
prescribed meal with composition of energy being the same for
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protein, and approximately 9 g dietary ﬁber per day. For breakfast
the menu consisted of wafﬂes (with syrup and margarine), diced
peaches in light syrup and scrambled eggs. For lunch the menu
consisted of roasted turkey breast, white sandwich bread, iceberg
lettuce, slice tomato, mayonnaise and mustard, potato chips and
gelatin snacks. For dinner the subjects received a lean hamburger
patty, sesame bun, leaf iceberg lettuce, a slice of tomato, mayon-
naise and mustard, grapes, 0reos and vanilla pudding. The studies
were designed to supply a relatively low level of ﬁber from the base
diet (around 9 g/day) in order to minimize interaction of the
additional viscous soluble psyllium ﬁber with other types of ﬁbers
in the diet. Psyllium at the various doses was added on top of the
base diet raising the daily total from 9 g from the undigested food
(placebo) up to a range of 19.2 g per day (10.2 g once a day plus ﬁber
from food) to 22.6 g (psyllium 6.8 g twice a day plus ﬁber from
food). The intent was to create a condition able to identify the in-
dependent effects of psyllium ﬁber on subjective satiety since
psyllium is not a common dietary ﬁber. Since these were cross-over
studies, all individuals were exposed for at least 3 treatment pe-
riods to a dietary ﬁber intake that was approximately within the
range of the daily American average ﬁber intake (approximately
10e18 g per day) (King, Mainous, & Lambourne, 2012).
Participants were instructed to fast overnight beginning at
12:00 a.m. before each test period visit and to adhere to all
continuance criteria. In Study 1, participants were allowed to go
home overnight and in Study 2, participants were housed overnight
at the study facility for convenience.
Individual hunger and desire to eat sensations were assessed
using a horizontal 100-mm VAS. The hunger scale was anchored on
the left by the phrase “Not at all hungry” (score ¼ 0) and on the
right by “As hungry as I have ever felt” (score ¼ 100). Participants
placed a mark on the scale corresponding to their sensation of
hunger. The numerical scores were not included on the blank form
completed by the participants. Distances on the VAS were
measured from the left border of the line in millimeters.
The VAS Desire to Eat Scale was constructed and implemented
in a similar manner as the VAS hunger scale, though with the in-
structions “Rate your desire to eat”. The anchor phrase on the left
was “No desire at all” (score ¼ 0) and “As strong as I have ever felt”
(score ¼ 100) on the right (Mattes, 2007).
In addition to VAS hunger and desire to eat scales, the Satiety
Labeled Intensity Magnitude (SLIM) Scale was used to assess
perceived hunger/fullness following a meal (Cardelloa, Schutz,
Lesher, & Merrill, 2005). The scale uses 11 descriptive phrases
placed along a vertical line scale anchored at the bottom by
“Greatest imaginable hunger” (score ¼ 100) and at the top by
“Greatest imaginable fullness” (score¼ ±100). Participants placed a
mark on the scale corresponding to their sensation of hunger/
fullness. The numerical scores were not included on the blank form
completed by the participants. Distances on the scale were
measured from the bottom border of the line in millimeters.
The order in which participants completed the 3 appetitive
assessment scales was randomized. Each participant was assigned
an assessment scale order and then followed that order for the
duration of the study.
2.2. Blinding process (common to both studies)
Studies were conducted double-blind. The test products were
similar with regard to taste and color but had slightly different
consistencies for the different doses due to gelling of the psyllium
when mixed with water. In Study 1, the participants were
instructed to drink their assigned test product within aminute or as
quickly as possible after mixing with water to minimize this subtledifference in consistency. Dosing was monitored and observed by
study personnel blind to treatment code. An adequate level of
isolation was maintained between the participants to avoid bias
and interference with the assessment of satiety variables. The in-
vestigators were also blind to treatment codes.
2.3. Sample size
Sizing of the ﬁrst study (Study1) was based, in part, on published
statistical power calculations for VAS assessment of satiety (Flint,
Raben, & Astrup, 2000). Calculations were based on the average
VAS satiety scores over the 4 h following a single meal. Assuming a
mean VAS hunger or satiety scale treatment difference of 5 mm,
completing the study with data from 25 evaluable participants was
estimated to provide approximately 80% power at a signiﬁcance
level of 5%. Assuming a participant dropout rate of 15%, approxi-
mately 30 participants were targeted for enrollment.
Sizing for Study 2 was based on mean and residual variance
estimates from the ﬁrst Study VAS Hunger, SLIM, and VAS Desire to
Eat 3-day averages. It was estimated that if 40 participants
completed Study 2 there would be at least 90% power to detect
treatment differences (6.8 g Psyllium vs. Placebo) comparable to
those observed in Study 1 at a signiﬁcance level of 5%.
2.4. Safety assessment (common to both studies)
Psyllium powder is an over-the-counter supplement considered
safe for daily use. Several publications and regulatory bodies have
assessed the safety of psyllium dietary ﬁber for daily consumption
(Anderson et al., 2000; FDA Final Rule, 2007; Oliver, 2000).
Therefore, safety assessments for both studies included only
routine laboratory data ﬁndings and the collection of adverse
events (AEs) reported by the participants or observed by the
investigator or study center personnel.
2.5. Test products administration (common to both studies)
Psyllium ﬁber (active) was supplied to the study site as Meta-
mucil Orange Sugar Free Fiber Singles (Procter & Gamble, Cincin-
nati, OH). Placebo was made from excipients used in Metamucil
Orange Sugar Free (maltodextrin, citric acid, natural and artiﬁcial
orange ﬂavors, aspartame and Yellow 6) to match appearance color
and taste.
2.6. Study 1. Dose-ﬁnding protocol
The objective of this study was to determine the between-meal
satiety effects of 3 different psyllium doses (3.4 g, 6.8 g, and 10.2 g)
mixed with 295.7 mL of water before meals versus placebo in
healthy participants over 3 consecutive days. This was a single-
center, randomized, double-blind, placebo-controlled, 4-way
cross-over study. Thirty healthy participants (19 men/11 women)
were enrolled and 28 completed the study. The study population
(mean ± SD) age and BMI were 34.1 ± 10.9 years and 24.8 ± 2.1 kg/
m2, respectively. Participants were served meals matched to esti-
mate individual energy requirements at rest with breakfast
comprising a substantial portion (average 28.4%) of daily energy
intake.
For Study 1, all individuals received a single daily dose on their
ﬁrst day. The doses of 3.4 g and 6.8 g were given twice a day on the
second and the third day. The dose of 10.2 g was given only once a
day.
All individuals started the study receiving only 1 dose of psyl-
lium ﬁber on the ﬁrst day before breakfast. This was done to assess
the potential impact of 3 single different doses on satiety responses.
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doses at breakfast only because all subjects received placebo with
their lunch followed by the afternoon satiety assessment. On the
second and third days, participants consumed their assigned test
product (3.4 g and 6.8 g) before breakfast and lunch, however, the
10.2 g was given only once daily (psyllium before breakfast and
placebo before lunch) to avoid potential side effects associated with
a single large dose of soluble ﬁber. Satiety was assessed by self-
ratings of hunger and desire to eat on independent visual analog
scales as well as hunger/fullness on the SLIM scale. Satiety assess-
ments were made immediately before and after breakfast and then
every 30 min for 4 h (10 morning assessments). Starting immedi-
ately after lunch, satiety assessments were made every 30 min for
an additional 4 h, for a total of 19 assessments per day.
2.7. Study 2. Effects of psyllium on energy restricted meal protocol
After the completion and data analysis of the dose-response
study described above, the effects of a single dose of psyllium
sugar-free powder (6.8 g/295.7 mL of water) on satiety indices were
evaluated. As the 6.8 g dose demonstrated the most consistent
statistically signiﬁcant satiety improvements in Study 1, the goal of
this study was to conﬁrm the efﬁcacy of the 6.8 g psyllium dose
before and after a lower energy-controlled breakfast. The trial also
spanned 3 consecutive dosing days. The energy restriction in the
breakfast simulated a less satiating breakfast commonly found in
low energy diets. Therefore, it tested the ability of psyllium in
curbing post-meal hunger under a presumably stronger hunger
signal. This study was a randomized, double-blind, placebo
controlled, 2-treatment, 3-period cross-over study with a different
group of forty-four healthy participants (25 men/19 women, 40
completed the study). The study population was similar to the ﬁrst
study with the mean ± SD age and BMI being 35.3 ± 10.4 years and
26.3 ± 3.6 kg/m2, respectively. On each dosing day, participants
consumed a breakfast providing energy equivalent to 15%e20% of
their estimated individual resting energy expenditure but with the
same proportions of carbohydrate, protein and ﬁber as in the ﬁrst
study. Satiety was assessed in a similar fashion to the ﬁrst study
with the same assessment scales. Satiety assessments were con-
ducted at 30 min intervals following the breakfast. Satiety was not
measured post-lunch.
2.8. Statistical analysis plan
The satiety data for each study were analyzed separately with a
general linear mixed model for repeated measures, reﬂecting the
fact that the study followed a crossover design. Each model
included the post-baseline satiety score as the response variable
with treatment and treatment period as ﬁxed effects and baseline
satiety score as a covariate. A separate model was ﬁtted for each
satiety measure (SLIM, VAS Hunger, VAS Desire to Eat) at each post-
baseline measurement time. The signiﬁcance level was set at 5%
(two-sided).
In Study 1 separate models were ﬁt to the post-breakfast and
post-lunch data. For Study 2, the mean over the entire post-
breakfast period was modeled, as well as the mean for the last
2 h preceding lunch. Each repeated measures model included
Period and Treatment as ﬁxed effects and Participant as a random
effect. Baseline satiety scorewas also included as a covariate, where
“Baseline” was deﬁned as the Day 1 pre-breakfast satiety
assessment.
Given the exploratory nature of Study 1, no attemptwasmade to
control the experiment-wise false-positive error rate. However, in
Study 2 a ﬁxed-sequence testing procedure was used to maintain
the overall false-positive error rate at 5%.Baseline satiety scores were assessed for balance across treat-
ments with a general linear mixed model analysis similar to that
described earlier, though in these models the baseline satiety score
was the response variable.
3. Results
3.1. Participant disposition
Dispositions of participants in both studies are shown as a ﬂow
chart in Fig. 1. Of the 30 participants randomized in Study 1, there
were 28 who completed. In Study 2 a total of 44 participants were
randomized and 40 completed.
3.2. Demographics and baseline satiety
Participant demographics and baseline satiety ratings are
summarized in Tables 1 and 2, respectively. There were no statis-
tically signiﬁcant differences between treatments with respect to
any satiety endpoint in either study.
3.3. Treatment compliance (common to both studies)
Meal consumption and test product compliance (assessed by
left-over weight) were similar across the test products. Participants
in these studies ate essentially all the food presented, as they were
instructed, insuring that the main independent variable was the
effects of different doses of psyllium ﬁber on subjective sensations
of satiety. A high percentage of meals (97%; Study 1) and test
product doses (99%; Studies 1 and 2) were completely consumed.
For Study 2, the average test product compliance rate met or
exceeded 99% for both test products across all of the test periods.
3.4. Study 1 results
The overall mean post-meal satiety scores (i.e., scores averaged
across all post-prandial measurement times and days) for the SLIM
scale in Study 1 were signiﬁcantly (p  0.031) higher (i.e., more
fullness and less hunger) for psyllium 6.8 g and 10.2 g compared
with placebo (Fig. 2). The highest score post-breakfast was seen
with Psyllium 10.2 g, which was only dosed once a day before
breakfast.
A more granular summary of the post-meal SLIM results is
provided in Fig. 3. The mean fullness/hunger effect of psyllium ﬁber
was sustained and relatively consistent through each between-
meal period.
The VAS Desire to Eat Scale and the VAS Hunger Scale post-
breakfast and post-lunch mean scores (i.e., scores averaged across
all post-prandial measurement times and days) were lower
signiﬁcantly or directionally (p 0.025 and p 0.052, respectively)
for all psyllium doses compared with placebo (Table 3). The overall
pattern of improvement in satiety with the psyllium doses was
similar after breakfast and lunch.
Considering all efﬁcacy analyses performed in Study 1, the
relationship between psyllium dose and satiety efﬁcacy generally
followed a trend of greatest efﬁcacy with the 10.2 g followed by the
6.8 g dose, the 3.4 g dose, and then placebo. Although a clear
separation between the 3.4 g low dose and the 2 higher doses (6.8 g
and 10.2 g) did occur in the ﬁrst period breakfast when all subjects
received only a single dose before breakfast, a non-signiﬁcant trend
of separation occurred between the 2 higher doses. All doses can be
compared at the post-breakfast satiety (ﬁrst dose of the day)
assessment since this is a cross-over study with washout between
periods. Therefore, the post-breakfast assessment of the perceived
satiety by the SLIM scale shows a clear trend towards dose-
Fig. 1. Disposition of All Subjects Screened for Study 1 and 2. N, number of subjects; BMI, body mass index; ITT, intent-to-treat; PP, per-protocol.
Table 1
Demographics.
Study 1 (n ¼ 30) Study 2 (n ¼ 44)
Age (years)
Mean (SD) 34.1 (10.9) 35.3 (10.39)
Range 19e54 19e55
Sex
Malea 19 (63.3%) 25 (56.8%)
Femalea 11 (36.7%) 19 (43.2%)
Race
Blacka 18 (60.0%) 28 (63.6%)
Caucasiana 12 (40.0%) 16 (36.4%)
Ethnicity
Hispanica 0 (0%) 1 (2.3%)
Not Hispanica 30 (100.0%) 43 (97.7%)
Height (cm)
Mean (SD) 172.1 (8.24) 169.7 (10.72)
Range 156.5e184.2 148.5e187.5
Weight (kg)
Mean (SD) 74.02 (11.27) 76.1 (13.87)
Range 52.80e93.17 52.2e107.3
BMI (kg/m2)
Mean (SD) 24.8 (2.12) 26.3 (3.57)
Range 20.6e28.1 18.6e31.8
BMI, body mass index.
a The number and percent of participants in each category.
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for the doses 3.4 g and 6.8 g was generally greater post-breakfast
than post-lunch. Of the 3 psyllium doses tested, the 6.8 g dose
demonstrated the most consistent statistically signiﬁcant im-
provements during the study.
The majority of the participants did not report any AEs onplacebo (72.4%) or on psyllium 3.4 g (69.0%), 6.8 g (67.9%), and
10.2 g (55.2%). Abdominal distension and ﬂatulence were more
frequently reported in participants taking psyllium than in those
taking placebo. There were no serious AEs, or withdrawals due to
AEs occurring during the study. Most AEs were mild in severity and
not different than previously known to occur with the oral sup-
plementation of psyllium ﬁber and were therefore considered
probably related to the test products.3.5. Study 2 results
There was a statistically signiﬁcant (p  0.008) decrease in the
3-day mean hunger and desire to eat ratings, as well as an increase
in fullness with psyllium ingestion relative to placebo (Table 4).
Similar statistically signiﬁcant (p 0.002) results were observed for
the 3-day mean hunger, desire to eat, and fullness in the 2 h
immediately prior to lunch. Psyllium ﬁber reduced between-meal
hunger consistently over the 4.5 h post-breakfast period (Fig. 4).
In Study 2, the mean satiety response to meal was of lesser
magnitude than in Study 1. This difference was expected due to
lower energy intake of the breakfast in Study 2 compared to Study
1. In Study 1, all individuals received a breakfast that comprised
approximately 28.4% % of their required energy intake for the day
according to REE. In Study 2 the participants received a smaller
breakfast (20% of daily REE). Independently, the average hunger
reducing effect of psyllium was equivalent to approximately 1/3 of
the hunger reducing effect of breakfast under placebo in both
studies (Fig. 5).
The number and percentage of participants who reported AEs
was similar for psyllium 6.8 g (3 [7.0%]) compared to placebo (3
[7.3%]). Gastrointestinal disorders (nausea and vomiting) and
Table 2
Baseline satiety scores.
Treatment Study 1 (n ¼ 28) Study 2 (n ¼ 40)
Baseline mean (SE)a P-valueb Baseline mean (SE)a P-valueb
Satiety labeled intensity magnitude scale
Placebo 41.0 (5.06) 0.708 44.6 (3.85) 0.944
Psyllium 3.4 g 43.2 (5.06) e
Psyllium 6.8 g 44.9 (5.06) 44.8 (3.83)
Psyllium 10.2 g 48.4 (5.06) e
Visual analog scale e desire to eat
Placebo 71.9 (3.77) 0.836 73.2 (2.53) 0.461
Psyllium 3.4 g 74.9 (3.77) e
Psyllium 6.8 g 70.9 (3.77) 74.8 (2.52)
Psyllium 10.2 g 72.0 (3.77) e
Visual analog scale e hunger
Placebo 72.5 (3.56) 0.999 71.9 (2.66) 0.362
Psyllium 3.4 g 72.2 (3.56) e
Psyllium 6.8 g 72.7 (3.56) 73.9 (2.64)
Psyllium 10.2 g 72.8 (3.56) e
a Means and standard errors calculated from a general linear mixed model analysis of the data.
b 2-sided p-values.
Fig. 2. SLIM scale post-meal means for Study 1. Error bars are not shown since they do not properly reﬂect relevant variability of cross-over design. SLIM, Satiety Labeled Intensity
Magnitude.
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There were no serious AEs, or withdrawals due to AEs occurring
during the study. Most AEs were mild in severity and not different
than previously known to occur with the oral supplementation of
psyllium ﬁber and were therefore considered probably-related to
the test products.4. Discussion
This manuscript reports the ﬁndings of 2 independent studies
investigating the ability of psyllium ﬁber supplementation to in-
crease fullness and decrease measures of hunger and desire to eat
in healthy volunteers.
A signiﬁcant satiety effect of psyllium was observed in both
studies. Study 1 investigated the satiety effects of 3 different doses
and regimen of psyllium between meals (breakfast to lunch and
lunch to dinner) over 3 days. The highest dose, 10.2 g was not
statistically different from 6.8 g given before breakfast although itshowed a tendency to cause a higher satiety effect than the 6.8 g
dose. Both the 6.8 g and the single dose of 10.2 g doses were su-
perior to the 3.4 g dose, suggesting that there is likely a dose-
response effect within the studied range. However, a larger sam-
ple population would be required to show clear differentiation
between these 2 doses. Nevertheless, the study fulﬁlled the pur-
pose of allowing the identiﬁcation of an effective and practical dose
of psyllium to achieve a signiﬁcant satiety effect. In the ﬁrst study,
the satiety effect occurred following a breakfast containing energy
equivalent to approximately 30% of the daily REE. In Study 2, the
6.8 g dose was used to verify whether the satiety effect of psyllium
following consumption of a less satiating breakfast in a similar
population of healthy individuals was reproducible. In Study 2, the
participants consumed a breakfast with an energy content equiv-
alent to only 15%e20% of the total daily REE. Therefore, as expected,
the satiating effect of the breakfast itself (with placebo beverage)
and the additional effect of psyllium were smaller in Study 2 than
Study 1. Nevertheless, the overall effects of 6.8 g of psyllium twice a
Fig. 3. SLIM scale means at each measurement time for Study 1. Error bars are not shown since they do not properly reﬂect relevant variability of cross-over design. SLIM, Satiety
Labeled Intensity Magnitude.
Table 3
Satiety treatment comparison by meal (Study 1, n ¼ 28).
Meal Treatment Adjusted mean (SE)b Treatment comparison P-valuesa
Psyllium 3.4 g Psyllium 6.8 g Psyllium 10.2 g
Visual analog scale e desire to eat scale
Post-breakfast Placebo 52.3 (4.00) 0.019 <0.001 <0.001
Psyllium 3.4 g 46.4 (4.00) 0.107 0.172
Psyllium 6.8 g 42.4 (4.00) 0.798
Psyllium 10.2 g 43.0 (4.00)
Post-lunch Placebo 52.2 (4.41) 0.025 0.002 0.020
Psyllium 3.4 g 46.7 (4.42) 0.372 0.923
Psyllium 6.8 g 44.6 (4.41) 0.422
Psyllium 10.2 g 46.5 (4.41)
Visual analog scale e hunger scale
Post-breakfast Placebo 51.3 (3.90) 0.052 0.001 <0.001
Psyllium 3.4 g 46.5 (3.90) 0.156 0.083
Psyllium 6.8 g 43.0 (3.90) 0.747
Psyllium 10.2 g 42.2 (3.90)
Post-lunch Placebo 51.9 (4.22) 0.020 0.007 0.010
Psyllium 3.4 g 46.2 (4.22) 0.699 0.797
Psyllium 6.8 g 45.3 (4.22) 0.896
Psyllium 10.2 g 45.6 (4.22)
a 2-sided p-values.
b Means and standard errors calculated from a general linear mixed model analysis of the data.
Table 4
Satiety treatment comparison (Study 2, n ¼ 40).
Treatment Mean (SE)a Mean difference P-valuesb
Visual analog scale e hunger
Placebo 61.0 (2.72) 3.9 (1.18) 0.002
Psyllium 6.8 g 57.1 (2.72)
Satiety labeled intensity magnitude
Placebo 21.7 (3.62) 6.7 (2.15) 0.002
Psyllium 6.8 g 14.9 (3.61)
Visual analog scale e desire to eat
Placebo 60.9 (2.79) 3.6 (1.30) 0.008
Psyllium 6.8 g 57.3 (2.79)
a Means and standard errors calculated from a general linear mixed model
analysis of the data.
b 2-sided p-values.
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average hunger reducing effect of 6.8 g of psyllium ﬁber was
equivalent to approximately 30% of the decrease in hunger in
response to breakfast with placebo in both studies.
It is reasonable to hypothesize that the effect of dietary psyllium
ﬁber supplementation on satiety might be useful in weight man-
agement. A meta-analysis of 22 studies concluded that a 14 g in-
crease in ﬁber intake is linked to a 10% reduction in energy intake
and may have beneﬁcial effects on long-term weight control
(Howarth et al. 2001). However, few studies have quantiﬁed the
relationship of self-reported appetite to subsequent energy intake.
A more recent review conﬁrms a trend towards weight loss with
high dietary ﬁber intake (Clark & Slavin, 2013). Nevertheless the
complexities involved in mechanisms of body weight control
Fig. 4. SLIM scale means at each measurement time for Study 2. The mean hunger reduction of psyllium ﬁber is sustained through the entire morning. Error bars are not shown
since they do not properly reﬂect relevant variability of cross-over design. SLIM, Satiety Labeled Magnitude.
Fig. 5. Clinical Meaningfulness of Psyllium Effect. The incremental average effect of Psyllium 6.8 g over the 4.5-h post-breakfast period on VAS Hunger is approximately 1/3 the
effect of breakfast. VAS, visual analog scale.
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it would need to be demonstrated through randomized trials
addressing speciﬁcally the endpoint of weight loss. It has been
suggested that a change of at least 10e15 mm in the VAS scale
corresponds to a signiﬁcant spontaneous decrease in energy intake
in ad libitum situations where desire to eat plays a considerable
role (Flint et al. 2000; Sadoul, Schuring, Mela, & Peters, 2014). The
ﬁndings of the studies in this report indicate that psyllium has a
satiety effect but further investigation is necessary to determine its
clinical relevance as a tool to promote decreased energy intake and
weight control.VAS satiety ratings alone do not always strongly correlate with
food and energy intake (de Graaf, 1993; Stubbs et al., 2000).
Learned behaviors, environmental cues and satiety together
strongly inﬂuence overall eating habits. Furthermore, VAS scales
are subjective tools and are sensitive to individual interpretations.
The satiety response to a meal is sensitive to perceived palatability
of the food, hunger, sensory-speciﬁc factors, cultural and social
cues, participant stress level and sleeping habits (Brunstrom,
Brown, Hinton, Rogers, & Fay, 2011; Hetherington, 2007;
Lemmens, Rutter, Born, & Westerterp-Plantenga, 2001; Morselli,
Leproult, Balbo, & Spiegal, 2010) among other inputs. The
J.M. Brum et al. / Appetite 105 (2016) 27e36 35contribution of these factors to the overall satiety response in VAS
is therefore difﬁcult to control and predict at the individual level.
However, all participants of our studies were exposed to the same
novelty of the environment by having the healthy volunteers
testing in a clinical pharmacology/metabolic research facility and
by monitoring food intake. In addition, the vast majority (95%) of
the participants consumed all of the food in 3 daily meals designed
to match their REE, as proposed by protocol.
Previous research has indicated that increasing total ﬁber intake
can help to reduce energy intake by decreasing hunger and/or
increasing fullness (Howarth et al. 2001; Venn & Mann, 2004).
There are several mechanisms by which different dietary ﬁbers
may inﬂuence hunger and food intake. Gastric distension and food
energy replacement by a bulking effect are commonmechanisms of
dietary ﬁbers associated more with satiation than inter-meal
satiety (Blackwood, Salter, Dettmar, & Chaplin, 2000; Wanders
et al. 2013). However, the ingestion of ﬁber may suppress energy
intake by inducing satiation and satiety (Blundell & Burley, 1987).
Dietary ﬁber affects satiety in many ways, depending on the
ﬁber type, and relating to its ability to bulk foods, increase viscosity,
gel in the stomach and ferment in the gut (Slavin & Green, 2007).
Psyllium is a soluble viscous ﬁber that has the ability to gel in the
stomach. Both aspects are important for the efﬁcacy of psyllium.
McRorie (2015) has extensively reviewed this issue and suggested
that the gel-forming ﬁbers (such as psyllium) may inﬂuence satiety
by several mechanisms, including delayed degradation and ab-
sorption of nutrients in the small bowel, leading to a ‘sustained’
delivery of nutrients; and delivery of nutrients to the distal ileum
with subsequent stimulation of feedback mechanisms like the ‘ileal
brake’ phenomenon (slows gastric emptying and small bowel
transit) and decreased appetite. These proposed mechanisms
involve the participation of gut hormones and the central nervous
system favoring higher sensations of satiety (De Graaf et al., 2004;
Howarth et al. 2001). Supporting this hypothesis, others demon-
strated that gel-forming ﬁbers increase satiety and reduce subse-
quent energy intake (Archer, Johnson, Devereux, & Baxter, 2004; Di
Lorenzo, Williams, Hajnal, & Valenzuela, 1988; Tiwary, Ward, &
Jackson, 1997; Wanders, Mars, Borgonjen-van den Berg, De Graaf,
& Feskens, 2014).
In our 2 studies, no biomarkers were collected that would
permit assessment of the correlations with the measured satiety
responses. The intention of these 2 studies was to demonstrate that
psyllium supplementation at acceptable and well tolerated doses
can affect signiﬁcantly the inter-meal satiety response. In addition,
previous work on satiety biomarkers suggested that presently
available biomarkers are not sufﬁciently sensitive to reﬂect satiety
sensations or predict food intake in clinical trials (De Graaf et al.,
2004).
There have been a limited number of placebo-controlled, ran-
domized trials investigating the effect of psyllium ﬁber on satiety.
Bergmann et al. (1992) studied the effects of 10.8 g of psyllium or
placebo on the gastric emptying and satiety of 12 healthy volun-
teers consuming a standard meal. Psyllium increased the sensation
of fullness and decreased hunger at the sixth hour after the meal
compared to placebo. The correlation between gastric emptying
and visual analog scale responses for hungerwas signiﬁcant in their
study. Rigaud et al. (1998) tested the effect of oral administration of
7.4 g of psyllium on the gastric emptying and satiety of 14 healthy
volunteers in a low energy diet in a placebo-controlled study. After
the meal, hunger feelings and energy intake were signiﬁcantly
lower during the psyllium than during the placebo treatments.
However, these investigators did not ﬁnd signiﬁcant psyllium
mediated alterations of gastric emptying in their study. The
magnitude of the satiating effects of psyllium in these studies was
similar to the range observed in our studies. Other investigationswith psyllium also showed some degree of efﬁcacy on satiety
(Delargy et al. 1997; Hylander & Rӧssner 1983; Salas-Salvado et al.
2008; Turnbull & Thomas, 1995) but were methodologically
different (open label, active comparators, different form or mixed
composition of ﬁbers) hampering comparisons with our ﬁndings.
In addition, the magnitude of the satiety effect observed in our
studies with psyllium ﬁber was similar to the effect observed by
others with oatmeal in a more recent comparative study with
ready-to eat cereal (Rebello et al. 2013). Similar to our interpreta-
tion, the authors attributed the differences in satiety to the vis-
cosity and hydration properties of the b-glucan content of oatmeal.
The most commonly reported AEs in these studies were
gastrointestinal symptoms. Initial gastrointestinal AEs are common
with start of ﬁber intake and are noted in published reports (Oliver,
2000). Nevertheless, all reported AEs were mild or moderate and
did not interfere with subject participation or affect the con-
sumption of the meals. The total number of subjects having AEs
with the 3.4 g and 6.8 g twice a day doses were not different than
placebo in these studies suggesting that the these doses would be
more appropriate for satiety effects without confounding abdom-
inal sensations.
In conclusion, the 2 studies included in this report conﬁrm that
psyllium supplementation before meals is well tolerated and can
signiﬁcantly affect satiety by decreasing hunger, increasing fullness,
and reducing the desire to eat between meals.
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